STAT3 suppresses Wnt/β-catenin signaling during the induction phase of primary Myf5+ brown adipogenesis

Area of Science:

• Cell Biology
• Metabolic Research
• Obesity and Diabetes Research

Background:

• Thermogenic fat is a key target for treating obesity and diabetes.
• The JAK-STAT pathway, including Tyk2 and STAT3, is implicated in brown fat development.
• STAT3's precise role in adipogenesis requires further elucidation.

Purpose of the Study:

• To investigate the role of STAT3 in the development of thermogenic fat.
• To understand the molecular mechanisms underlying STAT3-dependent adipogenesis.
• To explore potential therapeutic targets for obesity by examining the interplay of signaling pathways.

Main Methods:

• Primary preadipocyte isolation from newborn mice.
• Genetic manipulation (STAT3 knockout) and chemical inhibition.
• RNA interference (RNAi) to target specific pathways.
• Assessment of adipogenesis and Uncoupling Protein 1 (UCP1) expression.

Main Results:

• STAT3 is essential for preadipocyte differentiation and UCP1 expression during the induction phase.
• STAT3 deficiency blocks adipogenesis, which can be rescued by inhibiting Wnt ligand secretion.
• Canonical Wnt/β-catenin signaling mediates the differentiation block in STAT3-deficient cells.
• STAT3 deficiency leads to increased expression of Wnt ligands (1, 3a, 10b).

Conclusions:

• STAT3 is required for the early induction stage of adipogenesis.
• The JAK/STAT and Wnt/β-catenin pathways interact during early adipogenesis.
• Targeting the Wnt/β-catenin pathway may offer therapeutic strategies for obesity by modulating thermogenic fat development.